United States Antimony 2026 shareholder votes approved

United States Antimony Corporation reported results from its 2026 Annual Shareholders Meeting held on June 12, 2026.

(Moderate)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

United States Antimony Corporation reported results from its 2026 Annual Shareholders Meeting held on June 12, 2026. The company stated that each proposal received the requisite votes for approval. Director nominees drew strong support, with Lloyd Joseph Bardswich receiving 48,579,499 votes for and minimal abstentions. Other nominees, including Gary C. Evans, John M. Keane, and others, were also elected with large majorities. Two additional proposals each obtained substantial "for" votes, including one with 73,504,344 votes in favor, confirming overall shareholder support for the company’s agenda.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Votes for Lloyd Joseph Bardswich: 48,579,499 votes Votes for Gary C. Evans: 43,201,379 votes Votes for John M. Keane: 47,603,382 votes +3 more

6 metrics

Votes for Lloyd Joseph Bardswich 48,579,499 votes Director election at 2026 Annual Shareholders Meeting

Votes for Gary C. Evans 43,201,379 votes Director election at 2026 Annual Shareholders Meeting

Votes for John M. Keane 47,603,382 votes Director election at 2026 Annual Shareholders Meeting

Proposal vote – large approval block 73,504,344 votes for Non-director proposal at 2026 Annual Shareholders Meeting

Proposal vote – second item 68,138,061 votes for Non-director proposal at 2026 Annual Shareholders Meeting

Broker non-votes on director items 40,638,002 broker non-votes Reported for each director election in 2026

Key Terms

Annual Shareholders Meeting, broker non-votes, Schedule 14A, emerging growth company

4 terms

Annual Shareholders Meeting financial

"At the 2026 Annual Shareholders Meeting of United States Antimony Corporation"

An annual shareholders meeting is a yearly gathering where owners of a company review its performance, hear presentations from management, ask questions, and vote on important items such as board members, executive pay, and dividend policies. Think of it as a company town hall where votes and discussions can change leadership, strategy or payouts—outcomes that can directly affect a stock’s future performance and an investor’s rights and returns.

broker non-votes financial

"ABSTAIN | | | BROKER NON-VOTES ... 40,638,002"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

Schedule 14A regulatory

"definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission"

Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did United States Antimony (UAMY) disclose in the June 2026 Form 8-K?

United States Antimony reported the final voting results from its 2026 Annual Shareholders Meeting. The company stated that all proposals on the ballot received the requisite votes for approval, reflecting broad shareholder support for the agenda presented in its proxy materials.

Were all proposals at United States Antimony’s 2026 Annual Shareholders Meeting approved?

Yes, the company reported that each proposal received the requisite votes for approval. Director nominees and other matters on the ballot passed, indicating shareholders backed the items described in the definitive proxy statement and related supplemental Schedule 14A materials filed earlier in 2026.

How did United States Antimony (UAMY) director nominees fare in the 2026 vote?

Director nominees received strong majority support. For example, Lloyd Joseph Bardswich received 48,579,499 votes for, with only 535,908 abstentions, while other nominees such as Gary C. Evans and John M. Keane also secured large positive vote totals and significant broker non-votes reported.

What were the largest vote totals reported by United States Antimony in 2026?

One proposal received 73,504,344 votes for, 15,313,484 against, and 935,581 abstentions. Another proposal saw 68,138,061 votes for, 462,650 against, and 21,152,698 abstentions, both recorded without broker non-votes, indicating high participation levels among eligible shareholders.

Where can investors find details on the proposals United States Antimony shareholders approved?

The specific proposal descriptions are in United States Antimony’s definitive proxy statement on Schedule 14A filed April 20, 2026, its April 27, 2026 supplement, and additional definitive materials filed June 8, 2026, which together outline the matters presented for shareholder approval.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/15/2026 - 06:06 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported) June 12, 2026

	UNITED STATES ANTIMONY CORPORATION
	(Exact name of registrant as specified in its charter)

Texas

001-08675

81-0305822

(State or other jurisdiction

of incorporation)

(Commission

File No.)

(IRS Employer

Identification Number)

4438 W. Lovers Lane, Unit 100, Dallas, TX		75209
(Address of principal executive officers)		(Zip Code)

Registrant’s telephone number, including area code: (406) 606-4117

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	UAMY	NYSE American
Common Stock, $0.01 par value	UAMY	NYSE Texas

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the 2026 Annual Shareholders Meeting of United States Antimony Corporation (the “Company” and “USAC”) held on June 12, 2026 (“Annual Meeting”), each of the proposals submitted to a vote of the shareholders received the requisite votes for approval. Set forth below are the final voting results from the Company’s Annual Meeting for each of the proposals submitted to a vote of the shareholders:

To elect each of the seven directors named in the Proxy Statement for a term of one year

	FOR	AGAINST	ABSTAIN	BROKER NON-VOTES
Gary C. Evans	43,201,379	-	5,914,028	40,638,002
Dr. Blaise Aguirre	26,190,118	-	22,925,289	40,638,002
Lloyd Joseph Bardswich	48,579,499	-	535,908	40,638,002
Joseph A. Carrabba	38,505,154	-	10,610,253	40,638,002
John M. Keane	47,603,382	-	1,512,025	40,638,002
Jon R. Marinelli	43,014,787	-	6,100,620	40,638,002
Michael A. McManus	38,515,214	-	10,600,193	40,638,002

To approve an amendment to the Certificate of Formation to increase the number of shares authorized for issuance by the Company

FOR		AGAINST		ABSTAIN		BROKER NON-VOTES
73,504,344		15,313,484		935,581		-

To ratify the appointment of Sadler, Gibb & Associates, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026

FOR		AGAINST		ABSTAIN		BROKER NON-VOTES
68,138,061		462,650		21,152,698		-

For more information about the foregoing proposals, see the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 20, 2026, the supplement filed with the Securities and Exchange Commission on April 27, 2026, and definitive additional materials on Schedule 14A filed with the Securities and Exchange Commission on June 8, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	UNITED STATES ANTIMONY CORPORATION

Dated: June 15, 2026	By:	/s/ Shawn P. Winkler
	Shawn P. Winkler
	Interim Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents